HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.98334 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Zhicheng Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518033, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Papillomavirus Infections, Gene Expression Regulation, Neoplastic, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Evidence increasingly indicates that HPV infection plays a pivotal role in the initiation and progression of bladder cancer (BC). Yet, determining the predictive value of HPV-associated genes in BC remains challenging.
Methods
We identified differentially expressed HPV-associated genes of BC patients from the TCGA and GEO databases. We screened prognostic genes using COX and LASSO regression, subsequently establishing a risk prediction model. The model's precision and clinical relevance were gauged using Kaplan-Meier survival analyses and ROC curves. Functional enrichment, immune cell infiltration, and drug sensitivity analyses were performed across both high-risk and low-risk sets. PCR assays were utilized to measure the expression levels of genes.
Results
We identified 13 HPV-associated genes for our risk model. Among these, FLRT2, HOXC5, LDLR, SCD, GRM7, DSC1, EMP1, and HMGA1 were identified as risk contributors, while LPA, SERPINA6, ZNF124, ETV7, and SCO2 were deemed protective. Cox regression analysis verified that our model provides an independent prediction of overall survival (OS) in bladder cancer (BC) patients. Gene Ontology (GO) analysis revealed predominant gene enrichment in wound healing, extracellular matrix composition, and collagen-rich extracellular matrices. KEGG pathway analysis highlighted primary enrichment areas, including focal adhesion, the PI3K-Akt signalling pathway, and ECM-receptor interaction. Risk scores were correlated with tumor microenvironment (TME) scores, immune cell infiltration, and sensitivities to both chemotherapy and immunotherapy.
Conclusion
We have formulated a risk-assessment model pinpointing 13 central HPV-associated genes in BC. These genes present potential as prognostic indicators and therapeutic targets, emphasizing the intertwined relationship between HPV-induced BC progression and the immune landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518033, China.
- School of Medicine, Sun Yat-sen University, Shenzhen 518107, China.
Zitieren
APA
Tang, Z., Qian, Y., Wang, N., Chen, Y., Huang, H., Zhang, J., Luo, H., Lu, Z., Li, Z., He, Z., & Tang, F. (2025). HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.98334
Vancouver
Tang Z, Qian Y, Wang N, Chen Y, Huang H, Zhang J, et al. HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.98334
BibTeX
@article{Tang2025,
author = {Tang, Zhicheng and Qian, Yuxin and Wang, Ni and Chen, Yinqiu and Huang, Haojun and Zhang, Jiahao and Luo, Hongcheng and Lu, Zechao and Li, Zhibiao and He, Zhaohui and Tang, Fucai},
title = {HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.98334}
}
EUVIMED